tresuvi 1 mg/ml
aop orphan pharmaceuticals gmbh - austria - treprostinilum - sol. perf. - 1mg/ml - antitrombotice antiagregante plachetare
tresuvi 10 mg/ml
aop orphan pharmaceuticals gmbh - austria - treprostinilum - sol. perf. - 10mg/ml - antitrombotice antiagregante plachetare
tresuvi 2,5 mg/ml
aop orphan pharmaceuticals gmbh - austria - treprostinilum - sol. perf. - 2,5mg/ml - antitrombotice antiagregante plachetare
tresuvi 5 mg/ml
aop orphan pharmaceuticals gmbh - austria - treprostinilum - sol. perf. - 5mg/ml - antitrombotice antiagregante plachetare
ambrisentan aop 10 mg
genepharm s.a. - grecia - ambrisentanum - compr. film. - 10mg - alte antihipertensive alte antihipertensive
ambrisentan aop 5 mg
genepharm s.a. - grecia - ambrisentanum - compr. film. - 5mg - alte antihipertensive alte antihipertensive
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - blocaj blocant - toate celelalte produse terapeutice - inversarea blocadei neuromusculare indusă de rocuroniu sau vecuroniu. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
alprolix 1000 ui
swedish orphan biovitrum ab - suedia - eftrenonacog alfa - pulb.+solv. pt. sol. inj. - 1000ui - vitamina k si alte hemostatice factori ai coagularii sanguine
alprolix 2000 ui
swedish orphan biovitrum ab - suedia - eftrenonacog alfa - pulb.+solv. pt. sol. inj. - 2000ui - vitamina k si alte hemostatice factori ai coagularii sanguine
alprolix 250 ui
swedish orphan biovitrum ab - suedia - eftrenonacog alfa - pulb.+solv. pt. sol. inj. - 250ui - vitamina k si alte hemostatice factori ai coagularii sanguine